HOME     NEWSLETTER ARCHIVE     CME/CE INFORMATION     PROGRAM DIRECTORS     BLOG     EDIT PROFILE     RECOMMEND TO A COLLEAGUE

 
If you'd like to receive our monthly email issue, please complete the registration form below.

First Name *
Last Name *
Email *
Specialty *
How did you hear about us? *
Institution
Address
City
State/Province
Country

Zip


* Required Information



Follow DKBmed on Twitter

What is eCysticFibrosis Review?
Free to registered subscribers, with no fees or prerequisites required
A monthly review of journal literature by key topics, with access to available abstracts and full text articles
Timely commentary on current research, best practices and clinical management issues, provided by an expert panel of Cystic Fibrosis Specialists
7 bi-monthly newsletters and 5 alternating podcasts (audio interviews on related to key topics)
Delivered directly to your email box
Certified for credit - earn your CME/CE credits online

Some of the practical issues in the management of cystic fibrosis we expect to cover:
eCysticFibrosis Review Special Edition #1: review of the European Cystic Fibrosis Society's Hamburg conference
eCysticFibrosis Review Special Edition #2: review of the European Cystic Fibrosis Society's Hamburg conference
Exacerbation Therapies
Modifiers of CF Lung Disease
Exercise Testing & Outcomes
Interventions to Improve Nutrition
Emerging Pathogens

Intended Audience:
This activity has been developed for:
Pulmonologists
Pediatric Pulmonologists
Gastroenterologists
Pediatricians
Infectious Disease Specialists
Respiratory Therapists
Dieticians
Nutritionists
Pharmacists
Nurses and Nurse Practitioners
Physical Therapists
There are no fees or prerequisites for this activity.

Program Learning Objectives
After completing this activity, the participant will demonstrate the ability to:
Evaluate new and emerging disease modifying CF treatments and appropriate clinical strategies for their use.
Explain the importance of controlling environmental modifiers of CF lung disease and the latest clinically relevant data regarding generic modifiers.
Demonstrate a comprehensive foundational knowledge of P. aeruginosa.
Distinguish between existing and newly available antibiotic agents, alone or as combination therapy.
Adequately manage pulmonary exacerbations.
Identify factors and appropriate precautions to slow the incidence of Multiple Antibiotic-Resistant P. aeruginosa (MARPA).
Incorporate evidence-based strategies to improve patient adherence to antibiotic medications.
Incorporate evidence-based strategies to improve PERT adherence.
Implement better patient nutrition plans.
   
Who creates each newsletter?
Each month's issue is written by guest authors with expertise in the topic of focus. The program is overseen by expert editorial directors.






CME/CNE Information


Current Newsletter

Recommend to a colleague



Recommend to a colleague


PRIVACYLEGAL DISCLAIMERCONTACT US
Illustration © Michael Linkinhoker